Inflammatory and Infectious Processes Serve as Links between Atrial Fibrillation and Alzheimer's Disease

Gabriela Lopes Martins1, Rita Carolina Figueiredo Duarte1, Marat A Mukhamedyarov2

  • 1Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.

Insights

Atrial fibrillation (AF) and Alzheimer's disease (AD) share common inflammatory pathways. Understanding these links may lead to new treatments for both arrhythmia and cognitive decline.

Area of Science:

  • Cardiology
  • Neurology
  • Pathophysiology

Background:

  • Atrial fibrillation (AF) is a common arrhythmia linked to stroke and cognitive decline.
  • Alzheimer's disease (AD) is the leading cause of dementia with complex, not fully understood, pathogenesis.
  • Inflammation and infection are increasingly implicated in both AD and AF, suggesting a potential common etiology.

Purpose of the Study:

  • To elucidate the shared pathophysiological pathways between atrial fibrillation and Alzheimer's disease.
  • To identify overlapping predictive biomarkers for both conditions.
  • To discuss emerging pharmacological strategies for joint treatment approaches.

Main Methods:

  • Review of current literature on the pathophysiology of AF and AD.
  • Analysis of shared inflammatory and infectious mechanisms.
  • Exploration of potential overlapping biomarkers and therapeutic targets.

Main Results:

  • Identification of key shared pathways, including inflammation, linking AF and cognitive decline.
  • Highlighting of potential predictive biomarkers common to both conditions.
  • Discussion of novel therapeutic strategies targeting these shared pathways.

Conclusions:

  • A common link exists between atrial fibrillation and Alzheimer's disease, primarily driven by inflammatory processes.
  • Further research into shared biomarkers and joint pharmacological approaches is warranted for effective treatment of both conditions.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
11.5K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
328
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
687
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
660
Inflammation01:38

Inflammation

Overview
61.1K